Company ProfilePremium

Thorney Technologies Ltd

Company Profile Analysis

Ticker: TEK.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Thorney Technologies Ltd - Company showcase

Year Founded & Workforce

2001

Thorney Technologies Ltd logo

Thorney Technologies Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Thorney Technologies Ltd Overview

Thorney Technologies is a small-cap Australian listed investment company that gives public-market investors exposure to a mixed portfolio of listed and unlisted technology and innovation businesses across all stages of the corporate lifecycle, from seed and pre-IPO rounds to established ASX small caps. It is externally managed by the private Thorney Investment Group of Alex Waislitz, which sources deal flow through networks in Australia, Israel and the United States and co-invests alongside TEK and its sister LIC, Thorney Opportunities (TOP). At 30 June 2026 the portfolio of roughly 60 positions was valued at AUD 71.4 million, split 53% listed, 38% unlisted and 9% cash. Five consecutive years of losses since FY2021 have cut after-tax NTA from 48.5c to 21.5c, and the shares trade at a persistent discount of around 50–60% to NTA. The current strategic agenda is portfolio simplification, on-market buy-backs and an independent Board review of manager performance.


Company's own description

According to the FY2026 Directors' Report, TEK's principal activity is investing in global, listed and unlisted technology investments at all phases of the investment lifecycle. Earlier annual reports (FY2022) describe a mandate to identify listed and unlisted companies with new and disruptive technology and business models, spanning fintech, e-commerce, education, agriculture, medical, telecommunications, robotics and AI. The monthly NTA reports describe TEK as an LIC with a broad technology mandate, managed by the privately owned Thorney Investment Group under a long-term investment management agreement, with the objective of generating absolute returns for shareholders over the medium to long term.

Independent characterisation

TEK functions as a closed-end, permanent-capital venture and small-cap growth vehicle. Economically it is a hybrid of three things:

  1. An ASX micro/small-cap technology and healthcare activist-style equity portfolio (Level 1 listed equities of AUD 41.84 million at 30 June 2026, 53% of gross assets), concentrated in companies where the wider Thorney group (TIG + TEK + TOP) is frequently a substantial (>5%) holder.

  2. A venture/private-equity book (Level 3 unlisted equities and loan notes of AUD 28.98 million, 37–39% of gross assets), including Australian and US/Israeli private companies (e.g., Splitit, Mosh, Elenium Automation, Updater, Roman Health Ventures, ConsenSys, Theator).

  3. A small derivatives and cash sleeve (OTC options of AUD 0.58 million; cash of AUD 6.95 million at 30 June 2026; prime-broker facilities undrawn).

Business and revenue model

ElementTEK modelSource
Revenue typeNo product or service revenue. "Income" consists of net changes in fair value of investments (realised and unrealised), interest, dividends and minor other incomeFY2026 AR, Note 3
Income mix FY2026Net fair-value change -7.87m; interest 0.34m; dividends 0.06m; total investment loss -7.47mFY2026 AR
Cost baseExternal management base fee (0.75% of gross assets per half-year, i.e., ~1.5% p.a.); performance fee 20% of increase above high-water mark (none paid since 1H FY2022); directors' fees; admin, legal and fund administrationFY2026 AR remuneration report
Capital modelPermanent capital raised via equity (AUD 36.6m FY2021; AUD 25.3m FY2022); no borrowings; capital returned via on-market buy-backs since FY2023FY2022, FY2024, FY2026 ARs
Dividend modelProfits reserve of AUD 237.2m preserved for future dividends, but no dividends paid in any year coveredFY2026 AR Note 11
Value-chain positionCapital provider (seed to listed growth stage); frequently a board-level or substantial-holder engagement investor via the Thorney groupFY2026 AR; Dec 2024 NTA (Thorney representative on Dubber board from 1 Jan 2025)

Customer types and end-markets

TEK's "customers" are its shareholders: 1,067 registered holders at 19 August 2026 (down from 1,576 at 16 August 2024), dominated by the Thorney/Waislitz interests (32.75%), Rubino Group (11.28%) and Janet Heather Cameron/Mutual Trust (9.61%) (FY2026 and FY2024 ARs). The underlying end-markets are those of its investees, principally: healthcare and medtech (Clarity, Imricor, Vitrafy, Avita, Mesoblast, Doctor Care Anywhere, Mosh, Microba, Amplia, Mach7, Visioneering); fintech and payments (Splitit, Credit Clear, Raiz, Plenti, QuickFee, FinClear, eToro, Swyftx, Touch Ventures); industrial and climate technology (Calix, Hazer, Red Earth Storage, DUG Technology, Elenium Automation); and software/consumer tech (Yojee, Spacetalk, Dubber, Beonic, Tinybeans, ReadCloud, Updater, Outdoorsy, Cargomatic, Traackr, Buildxact).

Strategy

Stated strategy (FY2026 Annual Report themes, paraphrased)

The FY2026 Chairman's letter (28 August 2026) articulates five themes:

  1. Portfolio simplification — concentrating into a smaller number of higher-conviction holdings and liberating capital, on the view that a focused portfolio enables better capital allocation, deeper investee engagement and better long-term outcomes.

  2. Capital preservation and risk management amid elevated rates, geopolitical conflict, tariffs and trade tensions.

  3. Addressing the NTA discount — acknowledged as a source of shareholder frustration and a key Board priority; buy-backs at deep discounts are framed as accretive to continuing holders.

  4. AI and digital infrastructure — identified as defining investment themes likely to shape capital allocation for years.

  5. Opportunistic deployment — entering FY2027 with a simplified portfolio and financial flexibility to act on undervalued opportunities.

Strategic initiatives — last 24 months

InitiativeDateDetail / targetStatusSource
High-water-mark performance-fee mechanismEffective 1 Jan 2024; HWM reset 31 Dec 2024Aligns fee with market practice; intended to help narrow discountIn force; no performance fee earned sinceFY2024 and FY2026 ARs
On-market buy-backCommenced 10 Oct 2024; extended 3 Nov 2025; expiry 13 Nov 2026Up to 31,045,455 shares; 22,182,414 bought by 8 Sep 2026 (8,863,041 remaining); broker UBS Securities AustraliaActive; paused Mar–May 2025 to preserve cashFY2026 AR; Kalkine buy-back notices
Portfolio simplificationFY2026 onwardFewer positions; net realisations AUD 8.8m in FY2026; contract notes fell from 553 (FY2025) to 247 (FY2026)OngoingFY2026 AR
IMA extension24 Feb 2026Seven-year extension of initial term to 16 Dec 2033 exercised by the ManagerCompletedASX 24 Feb 2026
Manager performance reviewAnnounced 24 Feb 2026Independent Board sub-committee; Manager to undertake internal review and report backOngoing at 28 Aug 2026; no outcome published as at 18 Oct 2026ASX 24 Feb 2026; FY2026 AR
Board engagement in investeesFrom 1 Jan 2025Thorney representative appointed to Dubber boardIn placeDec 2024 NTA report
ESG / sustainability commitments—None articulated——
Cost programme—No formal programme; fees decline mechanically with gross assets——

Medium-term targets / guidance

TEK provides no quantitative guidance, NTA targets, return targets, dividend targets or discount-narrowing targets. The FY2026 "Prospects" section states only that the Board expects attractive technology-focused opportunities to continue to emerge. The stated investment objective is absolute returns over the medium to long term (monthly NTA reports).

Products & Services

For an LIC, the "product" is a single listed security offering exposure to the investment portfolio. The economically relevant catalogue is therefore the portfolio of investee companies. The table below lists every holding disclosed in the FY2026 Annual Report (list of investments at 30 June 2026), in order of fair value, with a brief description of the investee's business. Descriptions are drawn from TEK filings where available (marked †) and otherwise from general public knowledge of the investee.

The TEK security (the "product")

AttributeDetailSource
InstrumentFully paid ordinary shares, one vote per shareFY2026 AR
Inception of current strategyJanuary 2017Monthly NTA reports
Management fee0.75% of gross asset value per half-yearFY2026 AR
Performance fee20% of increase in measurable portfolio above high-water mark, per half-year, net of base fee; HWM reset at 31 Dec 2024FY2026 AR
Return since inception-0.05% p.a. (pre-tax, after fees, to 30 Sep 2026)Sep 2026 NTA report
3-year return-5.51% p.a. (to 30 Sep 2026)Sep 2026 NTA report
1-year return-20.08% (to 30 Sep 2026)Sep 2026 NTA report

Holdings at 30 June 2026 — listed investments

InvesteeTickerFair value 30 Jun 2026 (AUD)% gross assetsBusiness description
Vitrafy Life Sciences LtdVFY4,153,5715.3Cryopreservation technology; listed since FY2024 (held as Pty Ltd shares and convertible notes at 30 Jun 2024) †; top positive contributor FY2026 †
Imricor Medical Systems, IncIMR3,405,4864.3MRI-compatible cardiac ablation devices (US-domiciled, ASX-listed)
Clarity Pharmaceuticals LtdCU63,345,9014.3Radiopharmaceuticals with multiple products under US FDA IND programs †; share price rose 600%+ in FY2024 †
Credit Clear LtdCCR3,119,8754.0Digital debt-collection/receivables technology †; principal detractor FY2026 †
DUG Technology LtdDUG3,081,0773.9High-performance computing and geoscience data services; positive contributor FY2026 †
Doctor Care Anywhere Group PlcDOC2,828,2103.6UK digital health/telehealth provider
Mesoblast LtdMSB2,397,4963.0Allogeneic cell therapies
Yojee LtdYOJ2,341,5003.0Logistics/transport management SaaS; detractor FY2026 †
Raiz Invest LtdRZI2,233,8502.8Micro-investing and superannuation app
Spacetalk LtdSPA2,231,6742.8Children's smartwatch/phone devices and services
Plenti Group LtdPLT1,974,3702.5Consumer and green-energy lending fintech
Mach7 Technologies LtdM7T1,931,5622.5Medical imaging data-management software; TEK became a substantial holder in FY2026 †
Calix LtdCXL1,588,7502.0Multi-application mineral-processing technology targeting cement decarbonisation, agriculture and aquaculture †; positive contributor FY2026 †
Avita Medical LtdAVH1,499,0841.9Skin-regeneration devices (RECELL)
Beonic LtdBEO1,133,0681.4AI-driven customer/footfall analytics
Touch Ventures LtdTVL805,8001.0Listed investment company in consumer/payments technology
eToro Group LtdETOR780,3031.0Global retail trading and investing platform (held as unlisted at 30 Jun 2024; listed by 30 Jun 2026)
Hazer Group LtdHZR769,3551.0Low-emission hydrogen and graphite from methane
QuickFee LtdQFE767,1041.0Payment and financing solutions for professional-services fees; positive contributor FY2026 †
Amplia Therapeutics LtdATX744,7020.9Clinical-stage oncology (FAK inhibitor)
Dubber Corporation LtdDUB653,8150.8Cloud call-recording and voice-data platform †; Thorney representative appointed to DUB board 1 Jan 2025 †
Tinybeans Group LtdTNY590,8020.8Family photo-sharing and parenting platform
ReadCloud LtdRCL577,8500.7eLearning and digital textbooks for schools
Microba Life Sciences LtdMAP461,3170.6Microbiome testing and therapeutics (two line items: 459553 and 1764)
Terragen Holdings LtdTGH404,7280.5Agricultural biologicals; TEK ceased to be substantial holder FY2026 †
Rare Foods Australia Ltd—35,9180.0Wild-harvest seafood (listed in FY2024; shown without ticker FY2026)
Total listed—41,843,15853.2FY2026 AR

Holdings at 30 June 2026 — unlisted investments

InvesteeFair value 30 Jun 2026 (AUD)% gross assetsBusiness description
Splitit Payments Ltd4,843,8386.2Instalment payments using customers' existing credit cards; largest single holding
Mosh3,534,1764.5Australian online men's health and wellness platform (raised AUD 26m pre-IPO in Dec 2021 †); positive contributor FY2026 †
Red Earth Storage Ltd2,115,2312.7Residential battery energy storage (as named in filings)
360 Capital Fibreconx Trust2,044,9242.6Fibre-network infrastructure trust
Elenium Automation Ltd1,956,1362.5Airport and travel passenger-processing automation (held via convertible preference shares at 30 Jun 2024 †)
WSC Technologies1,514,6371.9Business not described in TEK filings
Visioneering Technologies Inc.1,155,9281.5Myopia-management contact lenses (formerly ASX: VTI; now unlisted)
FinClear Holdings Pty Ltd1,061,5711.3Market infrastructure, clearing and wealth technology
Proto Inc796,0811.0Holographic display/communications hardware
SH2 Holdings Pty Ltd791,1811.0Business not described in TEK filings
BikeExchange Ltd635,7560.8Online cycling marketplace (formerly ASX-listed)
Adacel Technologies Ltd602,4000.8Air-traffic management and simulation software (formerly ASX: ADA)
HiFi Labs538,6790.7Held via SAFE in FY2024 †; business not described in TEK filings
Updater Inc.518,4010.7US home-relocation app; formerly TEK's largest unlisted investment †
Awayco Holdings Pty Ltd491,7560.6Business not described in TEK filings
Packform Pty Ltd480,3750.6Business not described in TEK filings
58 Jarque Pty Ltd441,4670.6Wholly owned investment subsidiary †
Worthy Inc.363,9730.5US fintech; detractor FY2026 †
BabyQuip Inc.363,9720.5US baby-gear rental marketplace
GLX Holdings Ltd355,6150.5Business not described in TEK filings
Roman Health Ventures Inc.315,5600.4US direct-to-consumer telehealth (Ro)
Outdoorsy291,1780.4US RV and campervan rental marketplace
Swyftx Pty Ltd285,1570.4Australian cryptocurrency exchange
Cargomatic Inc279,3610.4US local trucking/freight marketplace
Buildxact Software Ltd269,8590.3Construction estimating and job-management software
Traackr262,2760.3Influencer-marketing analytics platform
Visual Amplifiers Holdings Pty Ltd235,5680.3Business not described in TEK filings
Whizz Technologies Pty Ltd201,4310.3Business not described in TEK filings
ConsenSys189,3300.2Ethereum blockchain software
Theator Inc.184,9710.2Surgical video AI
Brainvivo145,5890.2Business not described in TEK filings
Pogoseat Inc145,5890.2Business not described in TEK filings
Carbon Growth Opportunities Fund87,3530.1Carbon/climate-focused fund
GOARC39,6180.1Held via SAFE in FY2024 †
Viably Capital Inc7,7310.0Business not described in TEK filings
Total unlisted (incl. derivatives)29,560,67837.6FY2026 AR

Totals at 30 June 2026: investments AUD 71,403,836 (90.8% of gross assets); cash AUD 6,945,798 (8.8%); other assets AUD 318,277 (0.4%); gross assets AUD 78,667,911 (FY2026 AR).

Portfolio evolution — notable additions and exits

Holding30 Jun 2024 status30 Jun 2026 statusCommentSource
Clarity Pharmaceuticals15.56m, 14.9% of gross assets (largest)3.35m, 4.3%Significant profits realised in FY2024FY2024 and FY2026 ARs
Calix5.68m, 5.4%1.59m, 2.0%Negative in FY2024; positive contributor FY2026FY2024 and FY2026 ARs
Life3602.89m, 2.8%Not heldExitedFY2024 and FY2026 ARs
Imugene, BrainChip, Micro-X, Next Science, Xref, Envirosuite, Felix, Banxa, Spirit, Pentanet, Radiopharm, Sovereign Cloud, Chimeric, FiscalNote, Carbon Revolution, ARBEHeldNot in FY2026 listExited or written to nilFY2024 and FY2026 ARs
Nexdius Pty Ltd1.29mNot in listPrincipal detractor FY2026FY2024 and FY2026 ARs
Daisee Pty Ltd0.92mNot in listDetractor FY2026FY2024 and FY2026 ARs
Vitrafy Life Sciences1.00m (equity plus notes)4.15mLargest listed holding by Sep 2026 (7.9%)FY2024, FY2026 ARs; Sep 2026 NTA
Splitit Payments2.21m4.84mLargest holdingFY2024 and FY2026 ARs
Mosh2.00m3.53mUpliftFY2024 and FY2026 ARs
Imricor0.79m3.41mUplift and/or additionsFY2024 and FY2026 ARs
Mesoblast1.68m2.40mIncreasedFY2024 and FY2026 ARs
Yojee0.27m2.34mIncreased, then detractorFY2024 and FY2026 ARs

Most recent top holdings (30 September 2026)

RankListed holding% portfolioUnlisted holding% portfolio
1Vitrafy Life Sciences (VFY)7.9Splitit Payments6.7
2Clarity Pharmaceuticals (CU6)4.4Mosh4.9
3Imricor Medical Systems (IMR)4.0360 Capital Fibreconx2.8
4Doctor Care Anywhere (DOC)3.8Elenium Automation2.7
5Credit Clear (CCR)3.6WSC Technologies2.1

Source: Sep 2026 NTA report (via Kalkine). Allocation at 30 Sep 2026: 56% listed, 35% unlisted, 9% cash.

Financial Narrative

All figures AUD million unless stated; fiscal years ending 30 June. FY2022 from FY2022 AR; FY2023–FY2024 from FY2024 AR; FY2025–FY2026 from FY2026 AR. Conventional operating metrics (gross profit, EBITDA, capex) are not applicable to an LIC; the closest equivalents are shown and labelled.

Income statement

FY2021 reference: total investment income AUD 79.87m; total expenses AUD 17.71m (incl. performance fees AUD 14.07m); net profit AUD 52.85m; EPS 16.7c (FY2022 AR).

Margins. Because total investment income is negative in four of five years, gross, operating, EBITDA and net margins are not meaningful (n/m) for FY2022, FY2023, FY2024 and FY2026. For FY2025 only: pre-tax margin 12.1% (0.34/2.82) and net margin -165% (-4.66/2.82), the latter distorted by a AUD 5.00m deferred-tax charge. Revenue CAGR FY2022–FY2026 is n/m (sign changes).

Commentary. The income statement is a mark-to-market ledger. FY2022's AUD 84.1m unrealised loss marked the unwinding of the 2020–21 technology bubble; TEK still realised AUD 23.6m of gains that year and paid a AUD 1.9m performance fee for 1H FY2022 before the drawdown. FY2023–FY2024 losses were driven by listed small-cap de-ratings and, in FY2024, by approximately AUD 8.3m of prudent unlisted fair-value adjustments plus AUD 4.5m of unlisted assets written off at cost (FY2024 AR Chairman's letter and Note 6). FY2025 was the only year near break-even at the pre-tax line (AUD 0.34m), helped by AUD 1.2m of interest income. FY2026 presents an important composition shift: realised losses of AUD 18.9m (crystallising losses on exited positions as part of portfolio simplification) were partly offset by AUD 11.0m of unrealised gains on retained holdings (Vitrafy, DUG, QuickFee, Mosh, Calix). The AUD 6.70m tax charge reflects the full derecognition of the remaining deferred tax asset, taking the after-tax loss to AUD 16.4m. The expense base has been almost halved since FY2022 (excluding performance fees) because base fees scale with a shrinking gross asset value; however, the fixed-cost element means the expense ratio has crept up from 2.07% to 2.55%.

Balance sheet

Notes: "Short-term debt" in FY2024 is AUD 152,569 due to custodians and in FY2026 AUD 217,534 due to prime broker (operational settlement balances, not borrowings); TEK states it has no borrowings (FY2026 AR Note 17).

Equity reserves (30 Jun 2026): issued capital AUD 107.20m; profits reserve AUD 237.18m; accumulated losses AUD -266.81m (FY2026 AR). The profits reserve keeps growing (AUD 19.48m transferred in FY2026) even as total equity shrinks, because transfers are made from current-year profits on a per-entity basis that differs from the consolidated P&L presentation; the reserve is notionally available for dividends but no dividend policy has been articulated.

Tax losses: unrecognised tax losses of AUD 24.79m (tax-effected) at 30 June 2026; estimated unused gross revenue tax losses of AUD 99.1m (FY2025: AUD 78.6m; FY2024 AR disclosed AUD 135.1m — the FY2024-to-FY2025 reduction is not explained in the extracts reviewed) (FY2026 and FY2024 ARs, Note 5).

Commentary. TEK's balance sheet is debt-free and liquid at the listed level. The key balance-sheet events are (1) the steady contraction of net assets from AUD 175.5m (FY2021) to AUD 77.6m (FY2026), a 56% decline driven by losses (~AUD 113m cumulative FY2022–FY2026) and buy-backs (AUD 9.0m cumulative FY2023–FY2026), partly offset by the AUD 24.5m net raise in FY2022; and (2) the progressive write-off of the deferred tax asset, from AUD 19.1m (FY2022–FY2023) to nil (FY2026). The DTA derecognition means after-tax NTA now equals pre-tax NTA, removing a soft asset from book value; it also means any future realised gains can be sheltered by ~AUD 99m of gross revenue losses (subject to statutory tests), a latent value that is not on the balance sheet.

Cash flow statement

Sources: FY2022, FY2024, FY2026 ARs, statements of cash flows. Note: TEK classifies purchases/sales of its trading portfolio within operating cash flow and its long-term portfolio within investing cash flow, so "operating cash flow" for an LIC is primarily a measure of net portfolio realisation rather than recurring earnings. FY2025 buy-back cash outflow includes AUD 1,559 of costs (AUD 2.718m total).

Commentary. In FY2026 TEK was a net seller: trading sales of AUD 16.3m vs purchases of AUD 7.5m, no long-term investment, and AUD 1.9m spent on buy-backs, lifting cash from AUD 2.2m to AUD 6.9m. This is consistent with the stated "liberating capital" strategy. Recurring cash costs ("payments to suppliers") of ~AUD 2.5m p.a. against cash interest and dividends of only ~AUD 0.27m mean TEK must realise ~AUD 2.2m of investments each year simply to fund operations — roughly 3% of the portfolio.

Ratios

Calculated from audited figures (FY2021 opening equity AUD 175.55m and total assets AUD 187.74m from FY2022 AR). Not applicable / not meaningful: net debt/EBITDA (net cash, negative EBITDA), interest coverage (finance costs of AUD 0–2.4k), asset turnover (negative income), cash conversion cycle (no inventory, receivables or trade payables in the operating sense).

Trend synthesis. The five-year record is uniformly negative on return metrics: compounded NTA per share after tax fell from 36.4c to 21.5c (-41%, roughly -10.0% p.a.). The FY2025 "inflection" proved temporary. Positives are structural rather than performance-based: no leverage, high liquidity in the listed book, a falling absolute fee bill, and an accretive buy-back executed at an average 10.95c in FY2026 against NTA of ~21–26c.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityCountryOwnershipStatus / roleSource

Thorney Technologies Ltd

Australia

Parent

Listed investment entity

FY2026 AR

58 Jarque Pty Ltd

Australia

100%

Investment-holding subsidiary; fair value AUD 441467 at 30 Jun 2026

FY2026 AR Notes 19, list of investments

AR Fuels US LLC

USA

100%

Dormant legacy subsidiary (tax resident in Australia)

FY2026 AR

Biodiesel Producers Pty Ltd

Australia

—

Deregistered FY2022

FY2022 AR

Australian Renewable Fuels Adelaide Pty Ltd

Australia

—

Deregistered FY2022

FY2022 AR

Income component (AUD Mn)

Income component (AUD Mn)FY2022FY2023FY2024FY2025FY2026

Net realised gain or loss on investments

23.62-3.46-3.30-1.78-18.91

Unrealised gain or loss on investments

-84.10-20.09-9.603.3611.04

Net change in fair value of investments

-60.48-23.54-12.891.58-7.87

Interest income

0.470.691.111.200.34

Dividend income

0.110.300.070.000.06

Other income

0.010.000.020.050.00

Total investment income (loss)

-59.90-22.55-11.702.82-7.47

Asset class (AUD Mn)

Asset class (AUD Mn)FY2022FY2023FY2024FY2025FY2026

Level 1 listed equities

76.6959.7761.2054.3341.84

Level 2 OTC derivatives

0.000.000.001.360.58

Level 3 unlisted equities and loan notes

50.1636.6327.0931.6128.98

Total financial assets

126.8596.4088.2987.2971.40

Cash

9.3312.833.192.246.95

Revenue by Segment (%)

Mix (% of total financial assets)FY2022FY2023FY2024FY2025FY2026

Listed share (%)

60.562.069.362.258.6

Unlisted share (%)

39.538.030.736.240.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment

Level 3 by industry (AUD Mn)FY2021FY2022FY2023FY2024

Information technology and services

23.6826.8518.139.34

FinTech and e-commerce

10.237.806.078.66

Entertainment and media

0.792.562.782.71

Health care technology

2.706.414.194.07

Consumer and industrial products

2.606.475.432.30

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total investment income ("revenue" proxy, AUD Mn)

-59.90-22.55-11.702.82-7.47

Gross profit (AUD Mn, equals total investment income; no cost of sales)

-59.90-22.55-11.702.82-7.47

Management fees (AUD Mn)

2.932.161.711.611.37

Performance fees (AUD Mn)

1.920.000.000.000.00

Directors' fees (AUD Mn)

0.210.230.230.230.19

Legal and professional fees (AUD Mn)

0.440.370.450.320.36

Fund administration and operational costs (AUD Mn)

0.190.110.120.220.21

Other administrative expenses (AUD Mn)

0.100.100.110.100.10

Total expenses (AUD Mn)

5.782.972.622.482.24

Operating income = pre-tax result (AUD Mn)

-65.68-25.52-14.320.34-9.71

EBITDA proxy (pre-tax plus finance costs, AUD Mn)

-65.68-25.52-14.320.34-9.71

Income tax benefit or expense (AUD Mn)

20.530.00-7.40-5.00-6.70

Net profit or loss (AUD Mn)

-45.15-25.52-21.72-4.66-16.41

EPS basic (AUD cents)

-10.7-6.0-5.3-1.2-4.4

EPS diluted (AUD cents)

-10.7-6.0-5.3-1.2-4.4

Dividends per share (AUD cents)

00000

Weighted average shares (millions)

421.86424.69408.08384.50374.95

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Total expense ratio (%)

3.362.072.232.462.55

Management fee ratio (%)

1.701.501.461.601.56

Balance Sheet and Share Count (millions)

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (AUD Mn)

156.45130.37104.4896.9378.67

Cash and equivalents (AUD Mn)

9.3312.833.192.246.95

Financial assets at fair value (AUD Mn)

126.8596.4088.2987.2971.40

Deferred tax asset (AUD Mn)

19.1019.1011.706.700.00

Short-term debt (AUD Mn)

0.000.000.150.000.22

Long-term debt (AUD Mn)

0.000.000.000.000.00

Total debt (AUD Mn)

0.000.000.150.000.22

Net debt (AUD Mn, negative = net cash)

-9.33-12.83-3.04-2.24-6.73

Total liabilities (AUD Mn)

1.592.191.261.081.10

Total equity = net assets (AUD Mn)

154.86128.18103.2395.8577.57

Goodwill and intangibles (AUD Mn)

0.000.000.000.000.00

Working capital (AUD Mn)

94.1779.2868.8456.0648.18

Shares on issue (millions)

425.04418.10397.79377.83360.82

NTA per share after tax (AUD cents)

36.430.725.925.421.5

NTA per share before tax (AUD cents)

31.926.123.023.621.5

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (AUD Mn)

-12.5111.04-5.514.606.57

of which proceeds from sale of trading investments (AUD Mn)

51.6623.9411.4923.1316.27

of which payments for trading investments (AUD Mn)

-49.76-11.40-14.64-16.54-7.47

Investing cash flow (AUD Mn)

-9.15-6.39-1.04-2.660.00

Capex (AUD Mn, not applicable)

0.000.000.000.000.00

Free cash flow, OCF less capex (AUD Mn)

-12.5111.04-5.514.606.57

OCF plus investing cash flow (AUD Mn)

-21.664.65-6.561.946.57

Equity raised, gross (AUD Mn)

25.300.000.000.000.00

Share buy-backs (AUD Mn)

0.001.163.242.721.86

Dividends paid (AUD Mn)

0.000.000.000.000.00

Net change in cash (AUD Mn)

2.813.50-9.64-0.934.71

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE on average equity (%)

-27.3-18.0-18.8-4.7-18.9

ROA on average assets (%)

-26.2-17.8-18.5-4.6-18.7

ROIC (%, equal to ROE as no debt)

-27.3-18.0-18.8-4.7-18.9

Current ratio (x)

60.237.255.752.745.0

Debt to equity (x)

0.000.000.000.000.00

NTA per share change (%)

-24.9-15.7-15.6-1.9-15.4

Assets by currency (AUD Mn)

Assets by currency (AUD Mn)FY2022FY2023FY2024FY2025FY2026

USD-denominated assets

33.1322.7411.3310.056.96

CAD-denominated assets

2.011.450.861.820.00

AUD and other unexposed assets

121.31106.1892.2985.0671.71

Total assets

156.45130.37104.4896.9378.67

Growth (%)

Growth (%)FY2023FY2024FY2025FY2026

USD assets YoY (%)

-31.4-50.2-11.3-30.7

CAD assets YoY (%)

-27.9-40.7111.6-100.0

AUD assets YoY (%)

-12.5-13.1-7.8-15.7

Per-Share Data and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Share price at 30 June (AUD cents)

21.017.512.59.59.0

NTA per share after tax (AUD cents)

36.430.725.925.421.5

Discount to after-tax NTA (%)

42.343.051.762.658.1

Shares on issue (millions)

425.04418.10397.79377.83360.82

Market cap at 30 June (AUD Mn)

89.2673.1749.7235.8932.47

Shares bought back in year (millions)

0.006.9520.3119.9517.01

Buy-back spend (AUD Mn)

0.001.163.242.721.86

Average buy-back price (AUD cents)

0.0016.6415.9513.6210.95

Share Price History

PeriodStart price (AUD cents)End price (AUD cents)Change (%)Basis

1-year (30 Jun 2025 to 30 Jun 2026)

9.59.0-5.3

FY2026 AR table (see discrepancy note)

3-year (30 Jun 2023 to 30 Jun 2026)

17.59.0-48.6

FY2026 AR table

5-year (30 Jun 2021 to 30 Jun 2026)

43.09.0-79.1

FY2022 and FY2026 ARs

Current vs 30 Jun 2026

9.010.516.7

Sep 2026 NTA; StockInvest.us

52-week range

8.814.5—

Investing.com (as of 5 Oct 2026)

Relative to ASX 200 (1-year, date not specified)

——

-29.89 pts

Market Index

Valuation Multiples

MultipleTEKNotes

Price / NTA (x)

0.51

10.5c / 20.7c

Price / book (x)

0.51

NTA equals book value (no intangibles, no DTA)

P/E

n/m

Loss-making

EV / EBITDA

n/m

Negative EBITDA

EV / Sales

n/m

Negative total investment income

Enterprise value (AUD Mn)

~30.8

Market cap 37.0 less cash 6.2 (calculated); Yahoo Finance shows -31.76m, which appears to treat listed investments as cash-like

Peer P/NTA: BTI (x)

0.58

42% discount at 30 Jun 2026

Peer P/NTA: TOP (x)

0.66

57.0c / 86.7c at 31 Jul 2026 (calculated)

Capital Markets

ItemStatusSource

Analyst consensus / price targets

None; no broker coverage identified (MarketBeat shows no consensus or target)

MarketBeat

Technical rating (non-fundamental)

StockInvest.us "Buy Candidate", technical score 2.50 (15 Oct 2026); TipRanks technical signal "Strong Sell" (Oct 2026) — conflicting, low-value signals

StockInvest.us; TipRanks

Dividend history

No dividends paid or declared in any year reviewed (FY2017 to FY2026)

FY2022–FY2026 ARs

Dividend policy

None stated; profits reserve AUD 237.2m "preserved for future dividend payments"

FY2026 AR Note 11

Buy-back authorisation

Up to 31,045,455 shares; 8,863,041 remaining at 8 Sep 2026 (before ~5m further Sep purchases); expires 13 Nov 2026

Kalkine; FY2026 AR

Credit ratings (Moody's / S&P / Fitch)

None — no rated debt

—

Debt maturity profile

Not applicable — no borrowings

FY2026 AR Note 17

Analyst Conclusions

Management guidance and consensus

Management provides no quantitative guidance. Qualitatively, the Board expects attractive technology opportunities to continue to emerge, intends to keep simplifying the portfolio and to continue buy-backs, and remains optimistic about AI- and digital-infrastructure-driven opportunities (FY2026 AR). There is no sell-side consensus.

Bull case

  1. Asset-backed discount with accretive self-help. At 10.5c the market values TEK at ~51% of an NTA that is now "clean" (no DTA, no debt). Each buy-back tranche at ~10.5c is roughly 2x accretive, and the remaining authority plus a likely renewal could retire another 5–10% of shares.

  2. Concentrated winners and realisation optionality. Vitrafy, Splitit and Mosh together account for ~19.5% of the portfolio (Sep 2026); a liquidity event in Splitit or Mosh at or above carrying value would both validate the unlisted marks and crystallise cash, and ~AUD 99m of gross tax losses means gains would largely accrue to NTA untaxed.

  3. Governance catalyst. The independent sub-committee review (Feb 2026), rising Thorney ownership (32.9%) and a 10.26% protest vote create conditions for structural action — e.g., fee changes, a dividend from the AUD 237m profits reserve, or a capital-return mechanism — that could close part of the discount.

Bear case

  1. Track record. Since-inception returns are ~0% p.a. after nine years, three-year returns are -5.5% p.a., and NTA has fallen in four of the last five years; there is little evidence the strategy generates alpha in its current form.

  2. Entrenchment and value leakage. The Manager has extended the IMA to 2033; Thorney controls ~33% of votes, limiting shareholders' ability to force change. Fixed costs (~AUD 2.2m p.a.) are a rising share of a shrinking asset base and are funded by forced realisations.

  3. Valuation risk in the unlisted book. ~35–39% of the portfolio is Level 3, valued largely on investee-supplied information; FY2024 write-offs of AUD 4.5m and FY2026 unlisted write-downs of AUD 3.6m show marks can fall abruptly. The market's 50% discount may partly reflect scepticism about these values.

Catalysts and monitorables — next 12 months

Date / timingCatalystWhat to watch
~10–14 Nov 2026October 2026 NTATrend vs 20.7c; buy-back volume
13 Nov 2026Buy-back expiryRenewal and size of new authority
17 Nov 20262026 AGMRemuneration-report vote (two-strikes threshold is 25%); any update on sub-committee review; board renewal / independent appointments
Any timeSub-committee review outcomeFee restructuring, dividend initiation, manager change, wind-up or merger proposals (none announced)
Late Feb 20271H FY2027 Appendix 4DRealised vs unrealised mix; Level 3 movements
OngoingUnlisted liquidity eventsSplitit, Mosh, Elenium, Red Earth Storage, FinClear
OngoingThorney stakeCreep above 35%+ (no takeover-threshold issue until 20% under creep rules, which have already been exceeded — mechanism used is the 3% per six months creep exception or buy-back-driven increase; method not disclosed)
Late Aug 2027FY2027 resultsWhether the five-year loss streak is broken

Concluding analyst verdict

Thorney Technologies is best understood not as a technology company but as a small, externally managed, deeply discounted closed-end fund whose investment case now rests almost entirely on capital management and governance rather than on demonstrated investment skill. The numbers are unambiguous: after-tax NTA has fallen from 48.5c in FY2021 to 20.7c in September 2026, net losses have totalled AUD 113.5m over five years, and the since-inception pre-tax return to September 2026 is essentially zero. Peers such as Bailador have delivered positive returns and dividends through the same tech downturn, which undermines any argument that TEK's results are purely cyclical.

Against that, the balance sheet has become cleaner and more conservative. The deferred tax asset is gone, there is no debt, cash has tripled to ~AUD 6–7m, the portfolio is being concentrated, and buy-backs at around half of NTA are genuinely accretive. The holdings contain real assets — Vitrafy, Clarity, Imricor, Splitit and Mosh — whose realisation could move NTA meaningfully, and the ~AUD 99m tax-loss pool would shelter gains.

The pivotal variable is the Board sub-committee review launched in February 2026, set against the Manager's simultaneous extension of its mandate to 2033 and Thorney's rising 32.9% stake. If the review yields concrete discount-narrowing measures — a dividend from the AUD 237m profits reserve, a fee reduction, a tender or a structured exit — the 50% discount offers substantial upside without requiring any improvement in markets. If it does not, the shares are likely to remain a value trap, with fixed costs and buy-backs gradually shrinking the vehicle while the controlling holder's influence grows.

Verdict: a special-situations discount play. Key monitorable: the 17 November 2026 AGM.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleAppointedBackgroundSource

Craig Smith, B.Bus (Acct), GIA (Cert)

Company Secretary

22 Jun 2016

Company secretary of private Thorney Investment Group since 2009 and of Thorney Opportunities since 2013; director and company secretary of Anaeco; former CFO/company secretary of Baxter Group and Tolhurst Noall; TEK director during 2016 recapitalisation

FY2026 AR

Thorney Management Services Pty Ltd

Investment Manager (KMP)

IMA from Dec 2016/Jan 2017; extended to 16 Dec 2033

AFSL 444369; subsidiary of Thorney Investment Group Australia

FY2026 AR; ASX 24 Feb 2026

Board of Directors

NameTitleDirector sinceTenure (years)EducationPrior / other rolesSource

Alex Waislitz OAM

Non-Executive Chairman

9 Dec 2016

9.9

BEc, LLB (Monash); Harvard Business School OPM

Founder and Chairman of Thorney Investment Group; Chairman of Thorney Opportunities; co-owner of Australian Community Media (160+ regional publications); Collingwood FC Vice President for 20+ years to 2021; founder of Waislitz Foundation and Waislitz Family Foundation; OAM June 2023

FY2026 AR

Jeremy Leibler

Non-Executive Director

9 Dec 2016

9.9

BComm, LLB (Hons)

Partner, Arnold Bloch Leibler (M&A, capital raisings, activism, board disputes); third term on Australian Takeovers Panel; Corporations Committee, Law Council of Australia; Governor, Hebrew University of Jerusalem

FY2026 AR

Alan Fisher

Non-Executive Director; Chair of Audit & Risk Committee

29 Aug 2014

12.1

BCom (Melbourne); FCA; MAICD

Chair of TEK to Dec 2016; NED and Chair of Neuphoria Therapeutics Inc (formerly Bionomics); former NED of IDT Australia and Centrepoint Alliance

FY2026 AR

Martin Casey

Non-Executive Director; ARC member from 2 Jul 2026

22 Jun 2016

10.3

BEc, LLB (Monash)

Chief of Staff, Waislitz Family Office (from early 2022); long-term adviser to TIG; partner in Rampersand (tech VC); director of Fortlake Asset Management, Anaeco, ADG Global; former partner at an international law firm and investment banker at Credit Suisse

FY2026 AR

Tim Birch (former)

Non-Executive Director

8 Nov 2021 – 17 Nov 2025

4.0—

Ex-APAC Regional VP Salesforce; ex-Vietnam Country Manager Apple; Partnerships at Stripe

FY2024 and FY2026 ARs

“—” = not publicly disclosed.

Directors' Remuneration

NameFeesOtherSuperannuationTotal FY2026Total FY2025

Alex Waislitz

00000

Alan Fisher

50,00006,00056,00055,750

Jeremy Leibler (paid to Arnold Bloch Leibler)

56,0004,605060,60558,383

Martin Casey

50,00006,00056,00055,750

Tim Birch (retired 17 Nov 2025)

19,02202,28321,30555,750

Total directors

175022

4605

14283

193910

225633

Directors' Remuneration (FY2022–FY2026)

Manager fees (AUD Mn)FY2022FY2023FY2024FY2025FY2026

Base fees

2.852.101.671.611.37

Performance fees

1.880.000.000.000.00

Total paid to TMS

4.732.101.671.611.37

Governance Overview

AttributeAssessmentSource / basis

Board size

4 (reduced from 5 after Birch's retirement, Nov 2025)

FY2026 AR

Chair / CEO separation

No CEO; Chair (Waislitz) controls the Investment Manager — Chair is not independent

FY2026 AR

Independence (dossier assessment)

Waislitz: not independent (controls manager and 32.75% holder). Casey: not independent in substance (Chief of Staff, Waislitz Family Office). Leibler: independence questionable given his firm is TEK's solicitor and receives his fees. Fisher: appears independent. The Company's own classification is set out in its Corporate Governance Statement

FY2026 AR biographies

Committees

Audit & Risk Committee (Chair: Alan Fisher; members include Leibler and, from 2 Jul 2026, Casey; all directors invited to attend). Independent Board sub-committee established Feb 2026 to receive the Manager's internal performance review

FY2026 AR; ASX 24 Feb 2026

Meetings FY2026

6 Board meetings (Waislitz attended 4 of 6; Fisher and Casey 6; Leibler 5); 4 ARC meetings

FY2026 AR

Gender diversity

All-male board; a shareholder question at the 2025 AGM stated TEK has never had a female director (The Mayne Report, 22 Nov 2025)

The Mayne Report; FY2026 AR

Governance code

ASX Corporate Governance Principles 4th Edition, "if not, why not"; 2026 statement approved 2 Jul 2026

FY2026 AR

Board & Management Changes

DateChangeContextSource

8 Nov 2021

Tim Birch appointed

Added operating technology expertise

FY2022 AR

17 Nov 2025

Tim Birch retired at AGM

Not replaced; board reduced to four

FY2026 AR

24 Feb 2026

Independent Board sub-committee formed

Review of Manager performance and NTA discount

ASX 24 Feb 2026

2 Jul 2026

Martin Casey appointed to Audit & Risk Committee

Backfills committee after Birch's departure

FY2026 AR

Major Shareholders

RankHolderShares% issued capital
1

Thorney Holdings Proprietary Limited

100,295,19527.92
2

Rubino Group Pty Ltd (Rubino Group A/C)

40,532,66711.28
3

Mutual Trust Pty Ltd

34,539,7759.61
4

Tiga Trading Pty Ltd

11,720,4943.26
5

Venn Milner Superannuation P/L

10,000,0002.78
6

Citicorp Nominees Pty Limited

7,192,2232.00
7

Ace Property Holdings Pty Ltd

6,500,0001.81
8

Crathre Pty Ltd

4,579,0001.27
9

Tamit Nominees Pty Ltd (Itescu Family A/C)

4,545,4551.27
10

Thorney Holdings Proprietary Limited (second account)

4,484,3741.25
11

Halcycon Pty Ltd

4,000,0001.11
12

Perpetual Corporate Trust Ltd (Affluence LIC Fund)

4,000,0001.11
13

HSBC Custody Nominees (Australia) Limited

3,407,6630.95
14

Huoncan Super Pty Ltd

3,223,3530.90
15

Netwealth Investments Limited (Wrap Services A/C)

2,883,4090.80
16

The Dwyer Foundation Pty Ltd

2,726,0000.76
17

Mr Robert and Mrs Francine Velletri (S/F A/C)

2,719,7840.76
18

Mr Silvio and Mrs Mette Salom (Salom Super Fund A/C)

2,700,5320.75
19

Mabra Pty Ltd (Mabra Investments A/C)

2,173,5710.61
20

Mr Ian George and Mrs Jane Cooke

2,000,0000.56

Competitive Landscape

Key Competitors

CompetitorTypeRelevance to TEKKey comparative dataSource / status

Bailador Technology Investments (ASX: BTI)

LIC — expansion-stage private tech

Most direct listed peer for private-tech exposure; co-investor in Mosh

Post-tax NTA AUD 1.61/share at 30 Jun 2026; FY2026 NPAT AUD 6.9m; 2.8% post-tax portfolio return; discount 42% at 30 Jun 2026; fee 1.75% of pre-tax NTA; dividend policy 4% of pre-tax NTA

BTI FY2026 results (13 Aug 2026) via SmallCaps, Kalkine, StockWireX

Thorney Opportunities (ASX: TOP)

LIC — undervalued listed/unlisted equities, same manager

Sister vehicle competing for the same investor base

After-tax NTA 86.7c / pre-tax 93.0c at 31 Jul 2026; price 57.0c; market cap ~AUD 95.6m; pays fully franked dividends; Thorney group holds 35.9%

TOP Jul 2026 NTA report; Stockopedia

Acorn Capital Investment Fund (ASX: ACQ)

LIC — listed and unlisted micro-caps

Similar listed/unlisted hybrid model

——

WAM Microcap (ASX: WMI)

LIC — listed micro-caps

Competes for small-cap LIC investors

——

Pengana Private Equity Trust (ASX: PE1)

Listed trust — global private equity

Alternative listed private-markets exposure

——

Salter Brothers Emerging Companies (ASX: SB2)

LIC — emerging/tech companies

Tech-focused LIC peer

——

NAOS Emerging Opportunities (ASX: NCC)

LIC — emerging industrials

Small-cap LIC peer

——

Spheria Emerging Companies (ASX: SEC)

LIC — small/micro caps

Small-cap LIC peer

——

CVC Limited (ASX: CVC)

Listed investment house

Listed/unlisted hybrid

——

S&P/ASX All Technology ETF (ATEC) and other tech ETFs

ETF

Low-cost, liquid alternative for Australian tech exposure

——

Private VC managers (e.g., Rampersand, Square Peg, Blackbird)

Unlisted VC

Compete for early-stage deal flow

Not applicable

—

Peer Comparison FY2026

MetricTEKBTITOP

Latest post-tax NTA per share (AUD)

0.207 (30 Sep 2026)

1.61 (30 Jun 2026)

0.867 (31 Jul 2026)

Discount to post-tax NTA (%)

49 (30 Sep 2026)

42 (30 Jun 2026)

34 (31 Jul 2026, calculated)

FY2026 NPAT (AUD Mn)

-16.416.90—

FY2026 portfolio return (%)

-15.4 (NTA/share change, after tax)

2.8 (post-tax)

—

Base management fee

1.5% p.a. of gross assets

1.75% of pre-tax NTA

—

Dividend

Nil

Policy 4% of pre-tax NTA

Fully franked dividends paid

Market cap (AUD Mn)

37.0—

~95.6

Recent Developments

Upcoming: * buy-back expiry 13 November 2026; AGM Tuesday 17 November 2026 (FY2026 AR).

Company Snapshot

2001

Founded

Melbourne, Australia

Headquarters

SWOT Analysis

Strengths

  • Debt-free balance sheet: no borrowings; liabilities only AUD 1.10m against total assets AUD 78.67m at 30 June 2026 (FY2026 AR).
  • Cash and liquidity build: cash rose from AUD 2.24m to AUD 6.95m in FY2026, with prime-broker facilities undrawn (FY2026 AR; Sep 2026 NTA).
  • Accretive buy-back: 17.0m shares repurchased in FY2026 at an average 10.95c against year-end NTA of 21.5c — each dollar spent retired roughly two dollars of NTA (FY2026 AR).
  • Manager alignment by ownership: Thorney interests hold 32.75% and bought a further 10.68m shares in FY2026 (FY2026 AR).
  • Tax-loss shield: estimated unused gross revenue tax losses of AUD 99.1m, now off-balance-sheet after DTA derecognition (FY2026 AR Note 5).
  • Winners in the portfolio: Vitrafy (now 7.9% of portfolio), DUG, QuickFee, Mosh and Calix were named strong positive contributors in FY2026 (FY2026 AR; Sep 2026 NTA).
  • Lower fee drag in absolute terms: total expenses fell from AUD 5.78m (FY2022) to AUD 2.24m (FY2026) (FY2022, FY2026 ARs).

Weaknesses

  • Persistent losses: net losses in each of FY2022–FY2026, totalling AUD 113.5m (FY2022–FY2026 ARs).
  • NTA erosion: after-tax NTA down from 48.5c (FY2021) to 20.7c (Sep 2026), -57% (FY2022 AR; Sep 2026 NTA).
  • Flat since-inception returns: -0.05% p.a. pre-tax since January 2017; -5.51% p.a. over three years (Sep 2026 NTA).
  • Deep and persistent discount: 42% at 30 June 2022, widening to ~58% at 30 June 2026 (calculated from FY2026 AR performance table).
  • No dividend despite an AUD 237.2m profits reserve (FY2026 AR).
  • Governance concentration: Chair controls the Manager; only one director appears clearly independent; all-male board (FY2026 AR; The Mayne Report).
  • Illiquid unlisted book: Level 3 assets of AUD 28.98m (39% of investments incl. cash per Note 17) carry significant valuation uncertainty, a key audit matter (FY2026 AR).

Opportunities

  • Board sub-committee review (Feb 2026) could deliver structural change to close the discount (ASX 24 Feb 2026).
  • Realisation catalysts in the unlisted book (Splitit 6.7%, Mosh 4.9%, Elenium 2.7%) — any IPO or trade sale at carrying value would validate NTA (Sep 2026 NTA).
  • Tax losses would allow future realised gains to flow to NTA largely untaxed (FY2026 AR).
  • Continued buy-back: 8.86m shares of capacity remained at 8 Sep 2026; renewal beyond 13 Nov 2026 would extend accretion (Kalkine).
  • Mean reversion in small-cap tech after the ASX IT index's 37% FY2026 fall (BTI FY2026 results).
  • Initiating a dividend from the profits reserve could re-rate the shares toward peers that pay (BTI, TOP).

Threats

  • Continued small-cap de-rating: September 2026 alone cost -4.61% (Sep 2026 NTA).
  • Unlisted funding risk: FY2024 saw AUD 4.51m of unlisted assets written off at cost (FY2024 AR).
  • Manager entrenchment: IMA now runs to 2033; termination options for shareholders not detailed in sources reviewed (ASX 24 Feb 2026).
  • Shrinking shareholder base: registered holders fell 32% in two years to 1,067 (FY2024, FY2026 ARs).
  • Rising shareholder dissent: remuneration-report "against" vote rose from 2.85% (2024) to 10.26% (2025) (ASX AGM results).
  • Sub-scale cost ratio: further NTA decline would push the expense ratio above its current 2.55% (calculated).
  • Key-person risk around Alex Waislitz, identified as an operational risk by the Company (FY2026 AR).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
9 Apr 2025March 2025 NTA: decline amid global growth and inflation concerns; buy-back paused; Thorney stake 27.6% TipRanks; Mar 2025 NTA reportCash conservation; insider accumulation
7 Apr 2025Change of director's interest notice MarketBeat headlineInsider buying by Thorney entities
11 May 2025April 2025 NTA: slight increase; Avita and Dubber positive, Doctor Care Anywhere and Microba negative; Thorney stake 28% TipRanksRebound from April 2025 low
6 Jun 2025Increased stake in Envirosuite MarketBeat/TipRanks headlinePortfolio action
13 Jun 2025May 2025 NTA: slight decline; buy-back still paused; Thorney stake 28.3% TipRanksContinued volatility
13 Aug 2025July 2025 NTA report: NTA growth and portfolio additions MarketBeat headlinePositive month
26 Aug 2025FY2025 Appendix 4E and Annual Report: pre-tax profit AUD 0.34m, net loss AUD 4.66m after DTA charge; NTA after tax 25.4c ASX; FY2026 AR comparativesNear break-even year
11 Sep 2025August 2025 NTA: slight decline MarketBeat headline—
Oct 2025September 2025 NTA 25.9c pre-tax / 27.7c post-tax Oct 2025 NTA reportBaseline for 1-year comparison
16 Oct 2025Notice of virtual AGM for 17 Nov 2025 TipRanksGovernance
2–3 Nov 2025Buy-back extended: up to 31.05m shares FY2026 AR; KalkineCapital management resumes
Nov 2025October 2025 NTA 26.2c pre-tax / 28.0c post-tax; Thorney stake 30.4% Oct 2025 NTA reportPeriod high for FY2026
17 Nov 2025AGM: remuneration report carried 89.00% for / 10.26% against; Tim Birch retires; market cap ~AUD 49m ASX AGM results; The Mayne ReportElevated protest vote vs 2.85% in 2024
Jan 2026December 2025 NTA 25.7c pre-tax / 27.5c post-tax; Mach7 and Doctor Care Anywhere positive; Thorney 31.1% Dec 2025 NTA reportStable 1H
23 Jan 2026Highest buy-back price paid: 13.5c KalkineReference point
13 Feb 2026January 2026 NTA report HotCopper announcement list—
24 Feb 20261H FY2026 Appendix 4D: NTA after tax 25.8c (vs 25.4c at 30 Jun 2025); liquidity events remained limitedHalf-year stability
24 Feb 2026IMA extended by Manager to 16 Dec 2033; independent Board sub-committee to review Manager performance ASX announcement 24 Feb 2026Most significant governance event of the period
4 Mar 2026Change in substantial holding — Thorney Holdings HotCopperContinued insider accumulation
12 Mar 2026February 2026 NTA: 24.3c Listcorp (Mar 2026 report)Decline begins
13 Apr 2026March 2026 NTA 22.4c; Middle East conflict weighs on markets; cash AUD 4.2m; market cap AUD 40.8m; price 11.0c; Thorney 31.6% ListcorpSharp monthly fall (-7.8%)
14 May 2026April 2026 NTA report HotCopper—
12 Jun 2026May 2026 NTA 22.1c HotCopper; Kalkine—
30 Jun 2026Lowest buy-back price paid: 9.0c KalkineDiscount at widest
2 Jul 20262026 Corporate Governance Statement approved; Casey joins ARC FY2026 ARGovernance
3 Jul 2026Change in substantial holding — Thorney Holdings HotCopperInsider accumulation
Jul 2026June 2026 NTA 21.9c; 5,741,887 shares bought back; market cap AUD 32.4m; price 9.0c; Thorney 32.6%; cash AUD 7.0m TipRanks; KalkineYear-end trough
Aug 2026July 2026 NTA 21.6c Kalkine (Aug 2026 report)—
28 Aug 2026FY2026 Annual Report: net loss AUD 16.41m; DTA fully derecognised; NTA 21.5c; no subsequent events FY2026 ARFifth consecutive annual loss
1–8 Sep 2026Daily buy-backs (e.g., 250,000 shares at 10.5c on 8 Sep); cumulative 22.18m KalkineActive capital management
10 Sep 2026August 2026 NTA 21.7c KalkineMarginal uptick
13 Oct 2026September 2026 NTA 20.7c (-4.61% month; -20.08% 1-year); 5,142,183 shares bought back; falls in Credit Clear, Imricor, Raiz, Spacetalk, offset by Beonic and Avita gains; Thorney 32.9% Kalkine; TipRanksNew low; buy-back accelerating

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Income Statement: Revenue & Gross Profit: Gross profit (AUD M, equals total investment income; no cost of sales) rose from AUD -59.9 Mn in FY2022 to AUD -7.5 Mn in FY2026.
Thorney Technologies Ltd — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Gross profit (AUD M, equals total investment income; no cost of sales)-59.9-22.6-11.72.8-7.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Thorney Technologies Ltd, Annual Report 2026 (incl. Appendix 4E), 28 Aug 2026 (thorney.com.au)
  2. Thorney Technologies Ltd, Annual Report 2024, 27 Aug 2024 (thorney.com.au)
  3. Thorney Technologies Ltd, Annual Report 2022, 31 Aug 2022 (thorney.com.au)
  4. Thorney Technologies Ltd, Appendix 4E and Annual Report 2025, 26 Aug 2025 (announcements.asx.com.au)
  5. Thorney Technologies Ltd, Appendix 4D 1H FY2026, 24 Feb 2026 (investorpa.com)
  6. Thorney Technologies Ltd, Appendix 4D 1H FY2025, 25 Feb 2025 (announcements.asx.com.au)
  7. ASX announcement: Investment Management Agreement – Extension of Initial Term and Review of Manager Performance, 24 Feb 2026 — bulletin.webull.com (TEK announcement PDF)
  8. ASX announcement: TEK 2025 AGM Results of Meeting, 17 Nov 2025 (announcements.asx.com.au)
  9. ASX announcement: TEK 2024 AGM Results of Meeting, 12 Nov 2024 (announcements.asx.com.au)
  10. Monthly NTA reports: Oct 2025, Dec 2025, Dec 2024, Mar 2025, Jan 2023, Jun 2017 — thorney.com.au
  11. Net Tangible Asset Backing March 2026 — listcorp.com
  12. TEK Chairman's Update, 17 Mar 2017 — thorney.com.au
  13. Kalkine Media: September 2026 NTA report summary (13 Oct 2026); August 2026 NTA (10 Sep 2026); buy-back notice 8 Sep 2026; June 2026 NTA
  14. TipRanks: NTA summaries (Jan, Mar, Apr, May 2025; Jun and Sep 2026); Way2VAT and Raiz substantial-holding updates
  15. Market Index (TEK company page); Investing.com; Yahoo Finance; StockInvest.us; Simply Wall St; MarketBeat; IBISWorld; Stoxray; HotCopper announcement list; InvestSMART
  16. The Mayne Report, "6 questions lodged at 2025 Thorney Technologies virtual AGM", 22 Nov 2025
  17. Bailador Technology Investments FY2026 results (13 Aug 2026) via SmallCaps, Kalkine, StockWireX, InvestSMART
  18. Thorney Opportunities NTA reports (Jun and Jul 2026) and Stockopedia

Primary (company filings)

Secondary (market data and news)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.